PrEP Access Research Study
Researchers from Chapman University are conducting a study on pharmacy-based HIV pre-exposure prophylaxis (PrEP) to better understand barriers and opportunities for improving access.
Fast Facts
Adults who are HIV Negative & Currently Taking HIV PrEP Medications
Cisgender Women, Cisgender Men, Men Who Have Sex With Men, & Transgender People
Compensation
Provided
Conducted in
California
Study Background
This study is designed to explore how pharmacies can play a stronger role in expanding access to HIV prevention.
Pre-exposure prophylaxis (PrEP) is a highly effective medication that helps prevent HIV infection. California Senate Bill 159 allows trained pharmacists to prescribe PrEP directly in community pharmacy settings, but adoption has been limited. Many pharmacies face challenges such as limited staff, time, and resources to fully implement this service.
By gathering insights from patients taking PrEP and pharmacists providing care, researchers at Chapman University aim to identify real-world barriers and facilitators to pharmacy-based PrEP. The findings from this study will help inform strategies to expand PrEP delivery in community settings and improve access to HIV prevention care.
Study Background
This study is designed to explore how pharmacies can play a stronger role in expanding access to HIV prevention.
Pre-exposure prophylaxis (PrEP) is a highly effective medication that helps prevent HIV infection. California Senate Bill 159 allows trained pharmacists to prescribe PrEP directly in community pharmacy settings, but adoption has been limited. Many pharmacies face challenges such as limited staff, time, and resources to fully implement this service.
By gathering insights from patients taking PrEP and pharmacists providing care, researchers at Chapman University aim to identify real-world barriers and facilitators to pharmacy-based PrEP. The findings from this study will help inform strategies to expand PrEP delivery in community settings and improve access to HIV prevention care.
Additional Information
This study is being done to understand the barriers and facilitators that affect pharmacy-based PrEP services. The goal is to identify practical solutions that can improve access to HIV prevention through community pharmacies.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Ages 18+
- HIV negative and currently taking HIV PrEP medications
- Cisgender women, cisgender men, men who have sex with men, and transgender people
- Able to speak and write English
If you decide to join the study, you will:
Take part in a virtual focus group session on Zoom
Complete a short, anonymous survey (about 10 minutes)
Answer 15 questions with the Principal Investigator during the session
Spend about one hour total for the focus group session
Participants will receive a $50 Amazon e-gift card for completing the survey and focus group session.
There is no cost for you to participate in our research study.